Hangzhou Bay Shangyu Economic & Technological Development Zone IVD Innovation Industry Summit: Precision Dialogue on Cutting-Edge Technologies and Latest Trends in the IVD Sector

As a high-tech service sector prioritized for future development, the in vitro diagnostics (IVD) industry has become one of the most dynamic and fastest-growing industries worldwide. According to statistics from the China Medical Device Blue Book (2019), the market size of the IVD industry was projected to exceed RMB 80 billion in 2021. The year 2021 is destined to be a pivotal starting point for comprehensive economic recovery. For the IVD industry, this period represents both a significant test of production capacity and new opportunities for industrial transformation and development. Amidst these emerging opportunities and challenges, the IVD industry is poised to enter a new phase of rapid growth.

To continuously promote innovative development in the IVD industry, deepen dialogue and collaboration among government, industry, academia, research, and investment sectors, and lead the robust growth of the broader health industry, byHosted by the Hangzhou Bay Pharmaceutical Industry Alliance, co-organized by the Administrative Committee of Hangzhou Bay Shangyu Economic and Technological Development Zone and the Talent Office of the CPC Shaoxing Shangyu District Committee, and undertaken by VCBeat and VB100."Hangzhou Bay Shangyu Economic and Technological Development Zone IVD Innovation Industry Summit”held in Shangyu, Shaoxing on October 27.

This summit will be themed “Building New Momentum, Leading the Future” as the theme, inviting industry experts, department directors, executives of listed companies, executives of innovative enterprises, and senior investors to focus on cutting-edge technologies and the latest developments in the IVD field, and to explore innovation trends and iteration pathways in the IVD industry.

Multimodal:1 Welcome Dinner + 1 Innovative Industry Summit + 1 Park Open Day

The summit is structured around a “1+1+1” framework, with the establishment of1 Welcome Dinner, government leaders, park administrators, and guests visiting Yu will engage in direct, in-depth exchanges through closed-door, face-to-face meetings;1 IVD Innovation Industry Summit, over 60 industry representatives jointly explored innovative development in the IVD sector;1 Visit to the Industrial Collaboration Innovation Center and Pharmaceutical Industrial ParkOn the day of the summit, a special “Park Open Day” event will be organized, inviting distinguished guests and delegates to visit the park, with customized tour routes along the IVD industry chain designed for all visiting guests.

Strong Lineup:In-Depth Insights and Targeted Dialogues with Nearly 20 Industry Leaders

At the conference, government officials, executives from leading IVD companies, outstanding innovative entrepreneurs, industry experts, department heads, and seasoned investors, among nearly20 peopleDistinguished guests will deliver in-depth insights through keynote speeches and roundtable discussions. The summit also features a dedicated live Q&A session, enabling direct and targeted dialogue with industry leaders to thoroughly explore hot topics, cutting-edge technologies, and future trends.

VCBeat Frontline:Latest in the IVD IndustryDynamicsReflections on the Future

Where Is the IVD Industry Headed, and What Are the Prospects for China’s IVD Sector? This event will focus on areas such as POCT, clinical mass spectrometry, early cancer screening, and digital PCR, fostering in-depth discussions on topics including product innovation, integrated solutions, diagnostic technologies and scenario-based innovations in the digital era, and iterative development pathways.

Premium Services:From Talent Policies to Supporting Services

IVD innovation enterprises may encounter numerous challenges during their development, such as: How to break through bottlenecks in the resource supply chain? How to improve communication efficiency with upstream and downstream partners and reduce communication costs? How to further expand market share? What industrial and talent support policies and ancillary services are currently available? Government officials will provide on-site interpretations of these issues at the conference.

Hangzhou Bay Shangyu Economic and Technological Development Zone (Zhejiang Province Shangyu Economic and Technological Development Zone) is located on the south bank of Hangzhou Bay, at the center of the three major metropolitan areas of Shanghai, Hangzhou, and Ningbo. With a planned area of 175 square kilometers, it has attracted more than 1,300 enterprises, including over 40 listed companies, among which 19 are registered within the development zone. In 2020, the economic output of the development zone reached RMB 150 billion, with an industrial output value above designated size of RMB 112.7 billion and tax revenue of RMB 6 billion. It ranked 60th in the comprehensive evaluation of 218 national-level development zones across China and was listed as the 13th among the Top 30 Chemical Industrial Parks in China in 2020.

The Industrial Collaborative Innovation Center covers a total planned area of 150 mu. Developed under a model featuring government guidance, enterprise-led operations, and academic-industry collaboration, it is a comprehensive technological innovation hub integrating “project incubation, R&D, exchange and exhibition, testing and inspection, and professional services.” The Center leads the planning and design of the Economic Development Zone’s (EDZ) pillar industries, promotes bidirectional extension of the industrial chain, and fosters the generation of high-quality projects. It will serve as the sci-tech innovation center, pilot base, exhibition window, and service platform for the EDZ’s two major industrial clusters—new materials and modern pharmaceuticals—acting as an accelerator for industrial clusters, a converter between old and new growth drivers, and an integrator for innovation and entrepreneurship.

The Pharmaceutical Industrial Park is located in the modern pharmaceutical industry chain zone of the Economic and Technological Development Zone, with a total planned area of 426 mu. It serves as an accelerator for projects such as pharmaceutical preparations and medical devices. The park focuses on introducing pharmaceutical projects, including pharmaceutical preparations and medical devices, gradually forming an industrial park characterized by drug preparations and diagnostic reagents. Phase I has completed construction of 60,000 square meters, featuring standard factory buildings ranging from 1,500 to 6,000 square meters and a three-story comprehensive building. It provides a comprehensive and thoughtful office environment along with professional and humanized leisure spaces. Additionally, talent apartments have been built adjacent to the Pharmaceutical Industrial Park to provide accommodation guarantees for enterprise employees. Phase II is expected to be completed next year, while Phase III is currently under planning.